-
Lupin gets green light from FDA for generic Hyzaar, Cozaar
BALTIMORE, Md. Lupin Pharmaceuticals received regulatory approval last week for its generic antihypertensive agents, the drug maker said.
Lupin was granted final approval for hydrochlorothiazide-losartan potassium and losartan potassium, the generic versions of Merck's Hyzaar and Cozaar.
Hyzaar and Cozaar had combined annual sales of approximately $1.6 billion in the United States, based on IMS sales data for the 12 months ended in June.
-
Insurers ease pharmacy vaccine process
MOUNTLAKE TERRACE, Wash., and PORTLAND, Ore. Two health insurers in the northwest are taking steps to change the dynamics of preventive health reimbursement and broaden the role pharmacies play in flu vaccination efforts.
The two plans, Premera Blue Cross of Washington state and LifeWise Health Plan of Oregon, have announced new programs that both plans said will “remove barriers to care by providing improved access to common immunizations at pharmacies.”